# Pharmacogenetic-Guided Antidepressant Prescribing in Adolescents

> **NCT05965401** · NA · TERMINATED · sponsor: **University of Calgary** · enrollment: 11 (actual)

## Conditions studied

- Depression in Adolescence

## Interventions

- **OTHER:** Pharmacogenetic-guided dosing
- **OTHER:** GLAD-PC guided dosing

## Key facts

- **NCT ID:** NCT05965401
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-10-25
- **Primary completion:** 2025-05-02
- **Final completion:** 2025-05-02
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Low recruitment
- **Last updated:** 2025-05-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05965401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05965401, "Pharmacogenetic-Guided Antidepressant Prescribing in Adolescents". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05965401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*